WHO releases first global guideline on GLP-1 medicines for obesity treatment

who.int

WHO issued its first global guideline recommending GLP-1 therapies for treating obesity as a chronic disease. The guideline offers conditional recommendations for adults, excluding pregnant women, to use these medications long-term alongside lifestyle interventions, acknowledging limited long-term data and cost concerns. Obesity affects over 1 billion people globally and is linked to millions of deaths annually, requiring comprehensive strategies beyond medication.


With a significance score of 6.2, this news ranks in the top 0.1% of today's 31213 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: